Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
125 Cards in this Set
- Front
- Back
Holosystolic = pansystolic =
|
lasting through systole
|
|
AF is given by:
|
peak aortic pressure
"Peak aortic pressure is a surrogate for AF" |
|
EKG of LAE:
|
negative inflection in P of v1, tiny box wide and tiny box deep
|
|
R wave of v1 > S wave of v1 =
|
RVH
|
|
HF is characterized by:
(2) |
1. inc. preload
2. dec. contractility |
|
contractility =
|
the degree to which muscle fibers can shorten when activated,
independent of preload and AF. - depends on Ca2+ available |
|
****to treat *chronic* HFwrEF:****
(5) |
1. ACEI's (+ diuretic if edema/congestion)
2. ARB or H-ISN (if 1. not tolerated) 3. B-blocker (if deterioration or volume overload) 4. Aldosterone Antagonist (if advanced HF) 5. Digoxin (to improve QOL) |
|
***5 features of ACEI's:***
|
1. = balanced vasodilators
2. dec. AF 3. dec. preload 4. dec. aldosterone 5. limit maladaptive remodeling |
|
what does lowering the AF and preload by ACEI's do?
|
inc. CO
|
|
what does decreasing aldosterone do?
|
dec. intravascular volume/preload
=> dec. pulmonary congestion |
|
pulmonary congestion =
|
engorgement of pulmonary vessels with transudation of fluid into the alveoli and interstitial spaces
|
|
AII relationship to catecholamines:
|
it increases them
|
|
ACEI's do NOT decrease BP, b/c:
|
even though they dec. TPR, the increase in CO that they cause maintains the BP
|
|
***ACEI drugs are called:***
|
" -prils"
|
|
**diuretics are used in HF only if (3) are present:**
|
PE, congestion, peripheral edema
- given with ACEI's |
|
like nitrates, diuretics can decrease preload significantly, and CO:
|
by a bit
- again, be careful of doing that too much |
|
*example of a good thiazide:*
|
Metalozane
|
|
***ARB's are called:***
|
" -artans"
|
|
balanced vasodilator therapy =
|
hydralazine + isodinitrate
former opens up arteries, latter opens up veins |
|
when is balanced vasodilator therapy used?
|
when ACEI's can't be tolerated
|
|
what do nitrates do in HF?
|
dec. preload
=> dec. CO by a little - be careful not to dec. them too much |
|
arterial vasodilators like hydralazine decrease:
|
TPR
=> inc. SV => inc. CO (*new curve*) (given with B-blockers to stop reflex tachy) |
|
in general: **dec. perfusion of organs** =>
(2) |
activation of RAS and cat's
=> inc. BP, CO, and venous return => perfusion increases in the short term but now the heart has to push more volume against a higher pressure; => dec. EF => dec. renal perfusion => + fb on RAS |
|
negative effect of B-blockers on HF:
|
they decrease contractility
|
|
positive effects of B-blockers in HF:
(4) |
1. augment CO by decreasing HR
- make every beat count for more 2. block NOR-mediated arrhythmias 3. save lives 4. reverse downregulation of B-r's |
|
too much aldosterone causes:
(2) |
1. cardiac fibrosis
2. adverse ventricular remodeling |
|
what do Aldosterone Antagonists do?
(2) |
1. dec. retention of Na+/water
2. dec. hypertrophy/fibrosis |
|
2 Aldosterone Antagonists:
|
1. Spironalactone
2. Eplerenone |
|
cardiac glycosides like Digoxin are:
|
positive inotropes
|
|
inotropes and B-blockers both ________________, such that __________________________________
|
raise the curve,
such that at the same EDV, you get a higher SV => higher CO |
|
how does Digoxin work?
|
inhibits Na+/Ca2+ pump of myocytes
=> more Ca2+ inside for heart to use |
|
what does Digoxin result in?
(3) |
1. inc. contractility
2. inc. CO 3. dec. LV size |
|
**who gets Digoxin?**
|
**only pts with systolic dysfunction**
|
|
why is Digoxin so rarely used?
(3) |
1. VERY toxic
2. causes arrhythmias due to hypokalemia 3. narrow therapeutic index |
|
hypokalemia refers to little K+ in:
|
the blood
- b/c there's lots of Na+ coming out of myocytes in exchange for K+ coming in |
|
which drug is no good?
|
nesiritide
- a recombinant natriuretic factor |
|
to treat *acute* HFwrEF:
(2) |
1. ***B-AGONISTS***
- b/c it's so life-threatening, you need an immediate short-term solution 2. PDE-3 inhibitors |
|
3 B-agonists used for acute HFwrEF:
|
1. Dobutamine
2. Dopamine 3. Isoproterol |
|
what kind of acute HF is Dobutamine used for?
|
acute HF WITHOUT hypotension
|
|
what kind of acute HF is Dopamine used for?
|
acute HF WITH hypotension and poor renal perfusion
|
|
what kind of acute HF is Isoproterol used for?
|
acute HF with slow HR, high BP
|
|
of the 3 B-agonists, Dopamine is the only one that can increase:
|
renal perfusion
|
|
PDE-3 inhibitors increase:
|
Contractility
|
|
PDE-3 inhibitors are called:
|
" - rinones"
|
|
***when are PDE-3 inhibitors used?***
|
when vasodilators, inotropic agents, and diuretics **have failed**
|
|
****to treat HFpEF:****
(3) |
1. dec. pulmonary and systemic congestion
2. correct the UC of HF (HTN, ACS, etc) 3. NO role for ACEI's/, B-blockers, Inotropes |
|
cardiomyopathy =
|
primary myocardial muscle disease
- excludes HF secondary to other causes, e.g. HTN, valvular disease, etc. |
|
"ischemic cardiomyopathy" is a misnomer; it actually means:
|
CHF secondary to severe CAD
|
|
2 major/general effects of cardiomyopathy:
|
1. HF
2. arrhythmias |
|
3 major types of cardiomyopathy:
|
1. Dilated CM
2. Hypertrophic CM 3. Restricted CM |
|
DCM can be caused by:
(2 general) |
insult or inheritance
(e.g. alcohol abuse) |
|
top 3 causes of DCM =
|
1. idiopathic
2. genetic 3. viral |
|
DCM is most commonly inherited in:
|
AD fashion
|
|
DCM ~~ disease of:
|
sarcomeric proteins
|
|
DCM is characterized by:
(3) |
1. progressive dilation of ALL 4 chambers
2. => *systolic dysfunction* 3. progressive CHF |
|
appearance of DCM heart:
(3) |
1. severe cardiomegaly but *normal wall thickness*
2. dilation of ALL chambers 3. **intracardiac thrombi** |
|
histology of DCM:
|
boxcar nuclei
|
|
in DCM, the heart goes **straight to dilation (eccentric hypertrohy)**; dilation of chambers =>
|
progressive failure of leaflet adjustment
=> mitral rugurg => worse HF => volume-overload of LV => exacerbation of remodeling => CHF |
|
DCM often manifests as:
|
progressive CHF
|
|
clinical manifestations of DCM:
(4) |
1. often asymp
2. symp's of HF 3. MV, TV regurg 4. arrhythmias |
|
diagnosis of DCM:
(2) |
1. EF <40%
2. no significant CAD (both via echo) |
|
CXR of DCM: heart will be
|
>50% of thoracic chamber
- not diagnostic, but helps |
|
death in DCM occurs from:
(3) |
1. intractable HF
2. embolism/complications 3. arrthymias/SCD |
|
treatment for DCM =
(4) |
1. transplant (definitive treatment)
2. ICD to dec. arrhythmias 3. mechanical pump, ACEI's/, B-blockers, and Aldo Antagonists for HF 4. screen first-degree relatives |
|
other features of DCM:
(4) |
1. most common reason for heart transplant
2. variable rates of progression 3. idiopathic cases most fatal 4. prophylaxis is NOT indicated for thromboembolic events |
|
HCM is also called:
(2) |
1. asymmetric septal hypertrophy
2. idiopathic hypertrophic subaortic stenosis |
|
3 main features of HCM:
|
1. MASSIVE hypertrophy
2. stiff ventricle => abnormal filling (diastolic dysfunction) 3. intermittent outflow obstruction in 1/3 |
|
appearance of heart in HCM:
(5) |
1. marked hypertrophy, esp. of IVS and LV
(more often IVS > LV) 2. myocyte disarray 3. LV outflow tract plaque 4. abnormal thickening/scarring of both the subaortic septum and the anterior leafet (due to continuous abnormal contact b/w the two) 5. banana-shaped chamber-to-aorta |
|
***about 1/3 of pts with HCM have a:***
|
dynamic outflow obstruction
|
|
dynamic outflow obstruction is caused by:
|
SAM
- systolic anterior motion of the anterior leaflet when flow takes it |
|
what does SAM do?
|
sucks in the anterior leaflet toward the aorta
=> obstruction => regurgitation => dec SV => dec. CO |
|
Venturi is exacerbated by a/t that:
|
reduces ventricular volume
(dehydration, dec. venous return) |
|
**WITHOUT outflow obstruction, HCM looks like:
|
exaggerated HFpEF
- SV and Contractility are normal, but Compliance is decreased |
|
HCM is 100% _______________
|
genetic
- 50% of cases in AD fashion |
|
HCM ~~ powerful,
|
hyperkinetic heart contractions
|
|
clinical presentation of HCM:
(6) |
1. DOE (most common)
2. often asymp 3. MI and angina, even without athero 4. palpitations 5. syncope 6. SCD |
|
PhysEx/test findings of HCM:
(5) |
1. dec. SV
2. dynamic outflow murmur - crescendo-decresendo 3. S4 4. A-fib 5. mural thromboses |
|
angina in HCM results from:
|
supply-demand imbalance
- HCM => inc. muscle mass (demand) without inc. in vasculature to supply it - meanwhile, coronary arteries are compromised => further decrease in supply |
|
syncope is caused by:
|
insufficient CO to the brain
- esp. in SAM ~ exercise, dehydration |
|
to prevent SCD:
|
ICD's
(SCD ~~ disarray, fibrosis) |
|
criteria to qualify for an ICD in HCM:
(5) |
1. family history of SCD
2. history of syncope 3. non-sustained ventricular tachy 4. wall thickness >30 mm 5. abnormal BP response to exercise |
|
to diagnose HCM, it must meet these 3 criteria:
|
1. LV wall thickness >15 mm (normal <10)
2. FH/ i.d. of genetic mutation 3. exclusion of other causes of hypertrophy (e.g. HTN) |
|
***an HCM murmur is decreased while:***
|
***squatting***
- an AS murmur is decreased in valvsalva and standing |
|
gold-standard for HCM =
|
echo
|
|
EKG of HCM shows:
(2) |
1. LVH
2. T-wave inversions in v5, v6 |
|
in HCM, the degree of fibrosis predicts:
|
severity of disease and risk of arrhythmia
- fibrosis usually occurs in subaortic IVS, late |
|
HCM and genetic testing:
(4) |
1. NOT required for diagnosing it
2. negative tests don't exclude HCM 3. mutations do not change management 4. positive result => test first-degree family |
|
treatment of HCM:
(4) |
1. B-blockers for angina
2. surgical myectomy (gold standard) 3. alcohol septal ablation (if 2. no-go) 4. exclude most competitive sports |
|
Restrictive CM =
|
HFpEF taken to the extreme
|
|
3 features of Restrictive CM:
|
1. diastolic problem => can't fill
2. amyloid, sarcoid, iron, etc get into wall, heart can't expand 3. => stiff, inelastic ventricle w/ diastolic dysfunction |
|
stiff, inelastic ventricle w/ diastolic dysfunction =>
|
dec. contractility => CHF, eventually
RCM presents as CHF - low-voltage EKG, diminished QRS amplitude |
|
amyloid RCM ~~
(2) |
1. Congo red => bright green
2. poor compliance |
|
sarcoid RCM ~~
(4) |
1. granulomas
2. also in hilar LN's, lungs 3. treat with glucocorticoids 4. better prognosis than amyloid RCM |
|
hemochromatic RCM ~~
(1) |
hemosiderin (iron) accumulates in heart
|
|
fibroelastic RCM ~~
(1) |
children <2 y.o.
|
|
arrhythrogenic RV CM (aka ARVD) =
|
fibrofatty infiltration of RV,
which causes arrhythmias |
|
3 pitfalls of the ">50% of thoracic cavity" rule:
|
1. elevated hemidiaphragm
2. narrow ant-post diameter 3. pericardial effusion |
|
inc. pulmonary venous pressure on CXR shows:
|
redistribution of flow from the bases of the lung to the apices
|
|
***CXR should be ordered for a/o presenting with:
(2) |
chest pain or dyspnea
- can sense PE, pleural effusion |
|
the doppler is great for assessing:
|
flow through the valves
|
|
the trans-esophageal echo is the gold standard for:
|
excluding intrathoracic thrombus
|
|
2 features of Echo:
|
1. NO risk
2. gold standard for evaluating *valvular* structure and function |
|
***echo should be ordered for all pts who present with:
(2) |
1. HF
2. dyspena of unclear etiology |
|
nuclear imaging:
(3) |
1. uses Thallium or Technetium
2. tracks markers to find *hypo*perfusion 3. *enhances ischemic stress test* |
|
cardiac cathetirezation:
(3) |
1. measures pressure in the cardiac chambers
2. m's blood flow to calculate CO, vascular R 3. ~angiography |
|
pulmonary artery wedge pressure:
|
***closely matches LA pressure***
=> *estimates LV EDV/preload* |
|
***elevated PWP ~~ ***
|
**LHF** of any sort
|
|
summary of cath:
(4) |
1. invasive
2. exposure to Rx and dye 3. expensive 4. gold stand. for assessing filling pressure and CO, finding stenoses |
|
MRI should be ordered to characterize:
|
structure/function that's still unclear after echo
|
|
MRI is the gold stand. for assessing:
|
*cardiac* structure/function
- esp. in congenital heart disease |
|
what is used to image a suspected aortic dissection?
|
CT
|
|
MRI cannot be used in:
|
pts with ICD, pacemaker
|
|
Ca2+ blockers are contraindicated in:
|
LV (systolic) dysfunction - whenever EF is reduced
|
|
a cardiac index of 2.2 is:
|
very low and suggests hypoperfusion
|
|
ADHF is a sudden HF that can:
|
fall under EITHER heart failure,
HFwrEF *or* HFpEF, |
|
the same device can serve as both:
|
ICD and CRT => called a biventricular ICD
- but the problems each addresses (a-fib vs. dyssynchrony) are different |
|
PV loop: an increase in preload causes:
(3) |
1. inc. EDV
2. => inc. SV 3. dec. iso-contraction (due to higher volume, pressure nec. to open A3 is reached faster) |
|
PV loop: increase in AF causes:
(3) |
1. LARGE inc. in iso-contraction (due to inc. in Pressure necessary to overcome and push blood out)
2. inc. ESV 3. dec. SV |
|
PV loop: increase in Contractility causes:
(4) |
1. inc. iso-contraction
2. "longer" systole 3. dec. ESV 4. inc. SV |
|
how does HTN lead to LHF?
|
if the resulting, necessary hypertrophy becomes too much
|
|
paroxysmal nocturnal dyspnea ~~
|
hours
- vs. orthopnea, which ~~ minutes |
|
HF cells =
|
hemosiderin-laden cells in the *lungs*
|
|
RAS is activated when:
|
CO is decreased
|
|
cor pulmonale =
|
RHF due to PHTN
|
|
Rheumatic fever most commonly affects:
|
the Mitral Valve
|